Daily FNArena News - Australia

Fisher & Paykel Healthcare has signalled robust growth in its hospital applications but remains hindered by a patent dispute with ResMed.

Enterprise software provider TechnologyOne continues to tick all the right boxes, although some brokers suspect the stock price is becoming a little heady.

Gold and copper miner Newcrest has provided further clarity on growth plans for its key producing mines. Not all brokers are convinced.

Michael Gable of Fairmont Equities suggests the pullback for Brambles could be over, with the lower Aussie providing a tailwind.

Department store Myer flagged a positive performance in the first quarter but most brokers are wary of the headwinds prevailing in retailing.

Mineral processor and iron ore and lithium miner Mineral Resources’ AGM revealed so much opportunity one broker was prompted to upgrade to Buy.

Telstra has sparked speculation among brokers as to what it intends with its capital allocation strategy review.

FNArena provides a weekly update of Australian listed corporate bond issues, current pricing and yield data.

Graincorp’s earnings performance is expected to improve in FY17. That said, the degree of upside is unclear because of delays to harvests.

FNArena’s weekly update on short positions in the Australian share market.